Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.

Breast cancer research and treatment - 1 Mar 2007

Cybulski Cezary, Wokołorczyk Dominika, Huzarski Tomasz, Byrski Tomasz, Gronwald Jacek, Górski Bohdan, Debniak Tadeusz, Masojć Bartłomiej, Jakubowska Anna, van de Wetering Thierry, Narod Steven A, Lubiński Jan

Abstract excerpt

To investigate the contribution of a founder deletion in the CHEK2 gene to the burden of breast cancer in Poland we studied 4,454 women with breast cancer and 5,496 population controls. Cases and controls were genotyped for the presence of a 5,395 bp founder deletion that removes exons 9 and 10 of the CHEK2 gene. This deletion has recently been described in a Czech and Slovak population. The cases and controls...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Checkpoint Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CHEK2 gene

Share to Gene Deletion

Share to Genetic Predisposition to Disease

Share to Mutation

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 16897426
DOI: 10.1007/s10549-006-9320-y

Genes

CHEK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.PMID 16897426Read ↗

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.Semantic proximity Read ↗

Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients.Semantic proximity Read ↗

The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech RepublicSemantic proximity Read ↗

Limited relevance of the CHEK2 gene in hereditary breast cancer.Semantic proximity Read ↗

CHEK2-positive breast cancers in young Polish women.Semantic proximity Read ↗

Breast cancer predisposing alleles in Poland.Semantic proximity Read ↗

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention.Semantic proximity Read ↗

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.Semantic proximity Read ↗

CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases.Semantic proximity Read ↗

Association of two mutations in the CHEK2 gene with breast cancer.Semantic proximity Read ↗

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.Semantic proximity Read ↗

Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.